Tags - myeloma

FDA approves Xpovio combo for treatment of refractory multiple myeloma

TEHRAN, Jul 11 -Xpovio (selinexor) tablets have been approved for use in combination with dexamethasone to treat adults with relapsed refractory multiple myeloma , the U.S. Food and Drug Administration announced last week.

News ID: 41854 Publish Date : 2019/07/11

Young journalists club

FDA approves Xpovio combo for treatment of refractory multiple myeloma

China’s EXIM inks $1.5bn deal for high-speed rail in Iran (1 Comment)